ZA979644B - Heterocyclic compounds, compositions and uses. - Google Patents

Heterocyclic compounds, compositions and uses.

Info

Publication number
ZA979644B
ZA979644B ZA9709644A ZA979644A ZA979644B ZA 979644 B ZA979644 B ZA 979644B ZA 9709644 A ZA9709644 A ZA 9709644A ZA 979644 A ZA979644 A ZA 979644A ZA 979644 B ZA979644 B ZA 979644B
Authority
ZA
South Africa
Prior art keywords
compositions
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
ZA9709644A
Inventor
Poul Jacobsen
Svend Treppendahl
Paul Stanley Bury
Anders Kanstrup
Lise Brown Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA979644B publication Critical patent/ZA979644B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
ZA9709644A 1996-10-28 1997-10-18 Heterocyclic compounds, compositions and uses. ZA979644B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK120296 1996-10-28

Publications (1)

Publication Number Publication Date
ZA979644B true ZA979644B (en) 1998-04-28

Family

ID=8102133

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709644A ZA979644B (en) 1996-10-28 1997-10-18 Heterocyclic compounds, compositions and uses.

Country Status (8)

Country Link
EP (1) EP0934298A1 (en)
JP (1) JP2001502707A (en)
AU (1) AU4771997A (en)
CA (1) CA2269970A1 (en)
IL (1) IL129624A0 (en)
NO (1) NO992008L (en)
WO (1) WO1998018775A1 (en)
ZA (1) ZA979644B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU765159B2 (en) * 1998-12-30 2003-09-11 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
CO5251465A1 (en) 2000-01-26 2003-02-28 Pfizer Prod Inc COMPOSITIONS AND PROCEDURES TO TREAT OSTEOPOROSIS AND REDUCE CHOLESTEROL
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
NZ553834A (en) 2004-09-21 2010-03-26 Novogen Res Pty Ltd 7-hydroxy-3,4-diphenyl-chroman and chromene derivatives
WO2008113100A1 (en) * 2007-03-16 2008-09-25 Novogen Research Pty Ltd Method for inducing autophagy
EP2635273B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
US10980774B2 (en) 2015-02-02 2021-04-20 Mei Pharma, Inc. Combination therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (en) * 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
JP2001502707A (en) 2001-02-27
NO992008L (en) 1999-06-25
NO992008D0 (en) 1999-04-27
CA2269970A1 (en) 1998-05-07
EP0934298A1 (en) 1999-08-11
IL129624A0 (en) 2000-02-29
AU4771997A (en) 1998-05-22
WO1998018775A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
ZA978178B (en) Composition.
ZA97912B (en) Heterocyclic compounds.
ZA978579B (en) Herbicidal composition.
ZA9811599B (en) Ortho-anthranilamide derivatives as anti-coagulants.
ZA984849B (en) Compositions.
EP0956018A4 (en) Imidazole compounds, compositions and use
ZA9711313B (en) Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof.
ZA975261B (en) Composition.
GB9712317D0 (en) Composition, compound and use
GB9608488D0 (en) Compositions, processes and uses
GB9706597D0 (en) Compositions,processes and uses
HUP0002861A3 (en) Benzothiophene derivatives, and compositions containing the same
ZA979617B (en) Novel heterocyclic compounds.
ZA9811502B (en) Novel composition.
ZA979642B (en) Heterocyclic compounds, compositions and uses.
ZA979643B (en) Heterocyclic compounds, compositions and uses.
ZA979644B (en) Heterocyclic compounds, compositions and uses.
ZA979898B (en) Organic compositions.
ZA979649B (en) Heterocyclic compounds, compositions and uses.
GB9608489D0 (en) Compositions, processes and uses
ZA200006118B (en) Novel composition.
ZA979646B (en) Heterocyclic compounds, compositions and uses.
GB9706293D0 (en) Compositions, processes and uses
GB9706136D0 (en) Compositions,processes and uses